Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
28.1M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
157M
-
Shares change
-
-2.36M
-
Total reported value, excl. options
-
$138M
-
Value change
-
-$2.38M
-
Put/Call ratio
-
0.06
-
Number of buys
-
34
-
Number of sells
-
-42
-
Price
-
$0.88
Significant Holders of GeneDx Holdings Corp. - Class A Common Stock (WGS) as of Q3 2022
112 filings reported holding WGS - GeneDx Holdings Corp. - Class A Common Stock as of Q3 2022.
GeneDx Holdings Corp. - Class A Common Stock (WGS) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 157M shares
.
Largest 10 shareholders include Blackstone Inc. (27.7M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (17M shares), Casdin Capital, LLC (16.4M shares), Corvex Management LP (15.9M shares), BlackRock Inc. (13.4M shares), VANGUARD GROUP INC (9.31M shares), ORACLE INVESTMENT MANAGEMENT INC (8.4M shares), MARSHALL WACE, LLP (5.65M shares), Third Point LLC (5.55M shares), and PERCEPTIVE ADVISORS LLC (5M shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.